Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PROGENICS PHARMACEUTICALS INC | Financial_Report.xls |
| EX-10 - PROGENICS EXHIBIT 10 03/31/2012 - PROGENICS PHARMACEUTICALS INC | ex1003312012.htm |
| EX-31.2 - PROGENICS EXHIBIT 31.2 03/31/2012 - PROGENICS PHARMACEUTICALS INC | ex31_203312012.htm |
| EX-31.1 - PROGENICS EXHIBIT 31.1 03/31/2012 - PROGENICS PHARMACEUTICALS INC | ex31_103312012.htm |
| 10-Q - PROGENICS FORM 10-Q 03/31/2012 - PROGENICS PHARMACEUTICALS INC | form10_q03312012.htm |
| EX-32 - PROGENICS EXHIBIT 32 03/31/2012 - PROGENICS PHARMACEUTICALS INC | ex3203312012.htm |
Exhibit 12.1
Progenics Pharmaceuticals, Inc.
Ratio of Earnings (Loss) to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
|
Three Months
Ended
March 31,
|
Years Ended December 31,
|
|||||||||||||||||||||||
|
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
|||||||||||||||||||
|
Determination of earnings (loss):
|
||||||||||||||||||||||||
|
Income (loss) from operations
|
$ | (13,086 | ) | $ | 10,381 | $ | (69,820 | ) | $ | (30,612 | ) | $ | (44,672 | ) | $ | (43,688 | ) | |||||||
|
Add:
|
||||||||||||||||||||||||
|
Fixed charges
|
17 | 695 | 709 | 555 | 594 | 483 | ||||||||||||||||||
|
Earnings (loss), as adjusted
|
$ | (13,069 | ) | $ | 11,076 | $ | (69,111 | ) | $ | (30,057 | ) | $ | (44,078 | ) | $ | (43,205 | ) | |||||||
|
Fixed charges:
|
||||||||||||||||||||||||
|
Estimate of interest within rental expense
|
17 | 695 | 709 | 555 | 594 | 483 | ||||||||||||||||||
|
Fixed charges
|
$ | 17 | $ | 695 | $ | 709 | $ | 555 | $ | 594 | $ | 483 | ||||||||||||
|
Preferred stock dividends
|
$ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||||
|
Ratio of earnings (loss) to fixed charges and preferred stock dividends
|
* | 16 | * | * | * | * | ||||||||||||||||||
|
Coverage deficiency amount for total fixed charges and preferred stock dividends (1)
|
$ | 13,086 | $ | - | $ | 69,820 | $ | 30,612 | $ | 44,672 | $ | 43,688 | ||||||||||||
________________
|
(1)
|
For the years ended 2007 through 2010 and for the three months ended March 31, 2012, the Company’s coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.
|